Detalles de la búsqueda
1.
Real-world data on NGS using the Oncomine DxTT for detecting genetic alterations in non-small-cell lung cancer: WJOG13019L.
Cancer Sci
; 113(1): 221-228, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34704312
2.
Clinical impact of cerebral infarction in patients with non-small cell lung cancer.
Int J Clin Oncol
; 27(5): 863-870, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35192084
3.
Clinical Implications and Molecular Characterization of Drebrin-Positive, Tumor-Infiltrating Exhausted T Cells in Lung Cancer.
Int J Mol Sci
; 23(22)2022 Nov 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36430217
4.
Phase II study of multidisciplinary therapy combined with pembrolizumab for patients with synchronous oligometastatic non-small cell lung cancer TRAP OLIGO study (WJOG11118L).
BMC Cancer
; 21(1): 1121, 2021 Oct 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34663250
5.
Airway Pseudomonas aeruginosa density in mechanically ventilated patients: clinical impact and relation to therapeutic efficacy of antibiotics.
Crit Care
; 25(1): 59, 2021 02 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33573691
6.
Longitudinal monitoring of somatic genetic alterations in circulating cell-free DNA during treatment with epidermal growth factor receptor-tyrosine kinase inhibitors.
Cancer
; 126(1): 219-227, 2020 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31503343
7.
Heterogeneous Tumor-Immune Microenvironments between Primary and Metastatic Tumors in a Patient with ALK Rearrangement-Positive Large Cell Neuroendocrine Carcinoma.
Int J Mol Sci
; 21(24)2020 Dec 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-33352665
8.
Phase I study of salazosulfapyridine in combination with cisplatin and pemetrexed for advanced non-small-cell lung cancer.
Cancer Sci
; 108(9): 1843-1849, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28667792
9.
Successful concomitant therapy with mepolizumab and dupilumab for atypical eosinophilic granulomatosis with polyangiitis.
Allergol Int
; 71(2): 259-261, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35074267
10.
Dose escalation and pharmacokinetic study of carboplatin plus pemetrexed for elderly patients with advanced nonsquamous non-small-cell lung cancer: Kumamoto thoracic oncology study group trial 1002.
Oncology
; 88(4): 201-7, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25502447
11.
Psb28 is involved in recovery of photosystem II at high temperature in Synechocystis sp. PCC 6803.
Biochim Biophys Acta
; 1827(1): 50-9, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23084968
12.
Favorable outcome with hemoperfusion of polymyxin B-immobilized fiber column for rapidly progressive interstitial pneumonia associated with clinically amyopathic dermatomyositis: report of three cases.
Mod Rheumatol
; 24(2): 361-5, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24593215
13.
Negative impact of ratio of the microvascular area to tumor area on the response to EGFR-TKI in non-small cell lung cancer with an EGFR mutation.
J Thorac Dis
; 16(2): 1151-1160, 2024 Feb 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38505064
14.
Safety and efficacy of osimertinib rechallenge or continuation after pneumonitis: A multicentre retrospective cohort study.
Eur J Cancer
; 179: 15-24, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36470023
15.
Alternating Therapy With Osimertinib and Afatinib Blockades EGFR Secondary Mutation in EGFR-Mutant Lung Cancer: A Single-Arm Phase II Trial.
Clin Lung Cancer
; 24(6): 519-527.e4, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37344331
16.
Osimertinib as first-line treatment for elderly patients with advanced EGFR mutation-positive non-small cell lung cancer in a real-world setting (OSI-FACT-EP).
Lung Cancer
; 186: 107426, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37992594
17.
Association of Clostridium butyricum Therapy Using the Live Bacterial Product CBM588 with the Survival of Patients with Lung Cancer Receiving Chemoimmunotherapy Combinations.
Cancers (Basel)
; 16(1)2023 Dec 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38201474
18.
Clostridium butyricum therapy restores the decreased efficacy of immune checkpoint blockade in lung cancer patients receiving proton pump inhibitors.
Oncoimmunology
; 11(1): 2081010, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35655708
19.
Drug-Related Pneumonitis Induced by Osimertinib as First-Line Treatment for Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Real-World Setting.
Chest
; 162(5): 1188-1198, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35661746
20.
Alternating therapy with osimertinib and afatinib for treatment-naive patients with EGFR-mutated advanced non-small cell lung cancer: A single-group, open-label phase 2 trial (WJOG10818L).
Lung Cancer
; 168: 38-45, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35477147